-Tianlong ayuda a los hospitales de Tailandia a detectar la hepatitis de manera temprana con una solución de diagnóstico molecular XI’AN, China, 25 de mayo de 2023 /PRNewswire/ — Tianlong, una empresa innovadora de alta tecnología que se especializa en productos de diagnóstico molecular en China, se asoció con hospitales públicos en el norte de … Read more
XI’AN, China, May 25, 2023 /PRNewswire/ — Tianlong, an innovative high-tech company specializing in molecular diagnostic products in China, has partnered with public hospitals in northern Thailand to build up detection measures for hepatitis C (HCV) and hepatitis B (HBV), and for the early diagnosis and treatment of the viruses. Globally, more than 350 million … Read more
QUIOTO, Japão, 25 de maio de 2023 /PRNewswire/ –OMRON Healthcare Co., Ltd. (nas partes que se seguem denominada empresa) com sede na cidade de Muko, distrito de Quioto, Japão, tem o orgulho de celebrar seu 50º aniversário na produção de monitores de pressão arterial este ano. Desde a apresentação de seu primeiro monitor de pressão … Read more
KIOTO, Japón, 25 de mayo de 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (en adelante, la empresa), con sede en la ciudad de Muko, en la prefectura de Kioto en Japón, se enorgullece de anunciar para este año la celebración de su 50 aniversario en la producción de tensiómetros. Desde la presentación de su primer … Read more
HONG KONG and SHANGHAI, May 24, 2023 /PRNewswire/ — China is with great potential and very open for high standard players, says Jacqueline Zhang, Deputy General Manager of Ping An Asset Management Co., Ltd. (“Ping An AMC”), during a panel at the Future of Asset Management Asia event, hosted by the Financial Times in Singapore on … Read more
HONG KONG and SHANGHAI, May 24, 2023 /PRNewswire/ — China is with great potential and very open for high standard players, says Jacqueline Zhang, Deputy General Manager of Ping An Asset Management Co., Ltd. (“Ping An AMC”), during a panel at the Future of Asset Management Asia event, hosted by the Financial Times in Singapore on … Read more
SHANGHAI, May 24, 2023 /PRNewswire/ — BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the Investigational New Drug (IND) application for the clinical trial of its proprietary BRY812, a novel antibody-drug conjugate (ADC) targeting human LIV-1 for the treatment of advanced malignant tumors, has been accepted by the China National Medical Products Administration (NMPA) (Acceptance … Read more
KYOTO, Japan, 24. Mai 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (im Folgenden als das Unternehmen bezeichnet) mit Sitz in Muko City, Präfektur Kyoto, Japan, ist stolz darauf, in diesem Jahr sein 50-jähriges Jubiläum in der Produktion von Blutdruckmessgeräten zu feiern. Seit der Einführung des ersten manuellen Blutdruckmessgeräts und des Blutdruckmessgeräts mit Manometer im Jahr … Read more
SHANGHAI, May 24, 2023 /PRNewswire/ — BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the Investigational New Drug (IND) application for the clinical trial of its proprietary BRY812, a novel antibody-drug conjugate (ADC) targeting human LIV-1 for the treatment of advanced malignant tumors, has been accepted by the China National Medical Products Administration (NMPA) (Acceptance … Read more
KYOTO, Japon, 24 mai 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (ci-après appelée la Société), basée à Muko City, préfecture de Kyoto, au Japon, est fière d’annoncer la célébration, cette année, de son 50e anniversaire d’activité dans le secteur de la production de moniteurs de pression artérielle. Depuis l’introduction de son premier tensiomètre manuel et manométrique en … Read more